Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,017 | -38,484 | -191,086 | -144,324 | -87,467 |
| Depreciation Amortization | 1,642 | 833 | 3,889 | 2,796 | 1,651 |
| Accounts receivable | -1,820 | -8,507 | 4,639 | 4,694 | 617 |
| Accounts payable and accrued liabilities | -4,232 | -2,547 | -2,468 | -3,043 | -5,726 |
| Other Working Capital | -30,717 | -16,942 | -50,399 | -55,078 | -59,727 |
| Other Operating Activity | 31,595 | 23,388 | 58,194 | 44,159 | 38,045 |
| Operating Cash Flow | $-80,549 | $-42,259 | $-177,231 | $-150,796 | $-112,607 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -11 | -1,695 | -1,511 | -1,260 |
| Purchase Of Investment | -152,551 | -124,703 | -264,950 | -260,911 | -170,973 |
| Sale Of Investment | 126,659 | 79,450 | 311,658 | 288,733 | 158,555 |
| Investing Cash Flow | $-25,903 | $-45,264 | $45,013 | $26,311 | $-13,678 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 102,736 | 103,154 | 4 | 1 | N/A |
| Other Financing Activity | -79 | -79 | 40 | 107 | 6 |
| Financing Cash Flow | $102,657 | $103,075 | $44 | $108 | $6 |
| Beginning Cash Position | 58,988 | 58,988 | 191,162 | 191,162 | 191,162 |
| End Cash Position | 55,193 | 74,540 | 58,988 | 66,785 | 64,883 |
| Net Cash Flow | $-3,795 | $15,552 | $-132,174 | $-124,377 | $-126,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80,549 | -42,259 | -177,231 | -150,796 | -112,607 |
| Capital Expenditure | -11 | -11 | -1,695 | -1,511 | -1,260 |
| Free Cash Flow | -80,560 | -42,270 | -178,926 | -152,307 | -113,867 |